rinri hearing loss therapy

Rinri Therapeutics Secures $1.8M Seed Funding to Advance Novel Hearing Regeneration Therapy

SHEFFIELD, UNITED KINGDOM — Rinri Therapeutics, a biotechnology company developing a novel cell-based therapy to restore hearing, announced today that it successfully secured £1.4 million (approximately $1.8M USD) in seed funding. The financing, which was co-led by Boehringer Ingelheim Venture Fund and UCB Ventures and joined by BioCity, will support the ongoing growth of the…

Read More

Detecting Ear Infection at Home? Smartphone Technology Enables Accurate Detection of Middle Ear Fluid

Hearing care professionals, not to mention many parents of young children,  know tympanometry is helpful in the diagnosis of otitis media (middle ear infection). Another technique, differing from tympanometry, used to screen for the possibility of otitis media with effusion (OME) and acute otitis media is acoustic reflectometry.   Both techniques have plenty of evidence…

Read More

Person-Centered Care from the Patient’s Perspective, a New eBook from Shari Eberts

NEW YORK CITY, NEW YORK — Today, Shari Eberts, founder of LivingWithHearingLoss.com, announced the launch of her new e-book “Person-Centered Care from the Patient’s Perspective.” In it, Shari shares her personal hearing loss journey, examines her experiences with audiologists over the years and lays out her formula for person-centered care from the patient’s point of…

Read More
gn report north america president named

GN Posts Strong Growth in Q1 of 2019; Scott Davis Named President of GN North America

BALLERUP, DENMARK — The GN Group reported 19% organic revenue growth in the first quarter of 2019. Earnings Per Share (EPS) increased 25% compared to the same period last year.   GN Interim Report Q1 2019 Highlights   GN Hearing GN Hearing delivered 8% organic revenue growth in Q1 2019. Revenue growth was 10% including…

Read More
hearing loss family voices

Survey Finds “Voices of Family Members” as the Number One Sound Americans Would Miss If They Lost Their Hearing

DURHAM, NORTH CAROLINA — An international survey commissioned by auditory implant maker, MED EL, revealed the voices of family members or partners (67%) was the sound Americans would miss the most if they could no longer hear. Conversations with friends and loved ones (81%) was the highest mentioned everyday situation that would be affected by…

Read More
nidcd director tucci

Dr. Debara Tucci Named as the Next Director of the National Institute on Deafness and Other Communication Disorders

BETHESDA, MARYLAND — National Institutes of Health Director Francis S. Collins, M.D., Ph.D., has selected Debara L. Tucci, M.D., M.S., M.B.A., to lead the National Institute on Deafness and Other Communication Disorders (NIDCD) as its new director.  Dr. Tucci is currently professor of surgery and director of the cochlear implant program in the Division of…

Read More
demant acquires earq

EarQ Becomes Part of Demant Group

SYRACUSE, NEW YORK — EarQ, a privately-held, US-based network of hearing healthcare providers, announced today that the company has joined Demant. As an independent business within the Demant Group, EarQ “will continue its successful business strategy without interruption, providing a multi-brand offering of hearing technology under the EarQ brand to a nationwide network of more…

Read More
clinical study tomi scope eardrum

PhotoniCare Announces Initiation of Clinical Study in Patients Undergoing Surgery for Chronic Middle Ear Infection

​​​​CHAMPAIGN, ILLINOIS — Medical device company PhotoniCare Inc., today announced the successful initiation of a multi-site registered clinical study to evaluate the imaging capabilities and image analysis performance of the PhotoniCare TOMi Scope. According to the announcement, Children’s National Health System (Washington, D.C.) is the first initiated of two clinical sites involved in this registered multi-site clinical study, along…

Read More